Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Rubin

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
Continuum (Minneapolis, Minn.)|August 5, 2017
Shared Medical Decision Making in Consideration of Opioid Therapy in a Patient With Restless Legs SyndromeMichael Rubin
The American Journal of Bioethics : AJOB|June 14, 2016
Should We Offer Blood Transfusions as a Palliative Therapy?Michael Rubin
The Journal of Supportive Oncology|August 12, 2005
Paraneoplastic syndromes and the nervous systemMichael Rubin
The New England Journal of Medicine|October 11, 2013
Observation careJodi Nudelman, Michael Rubin
The Journal of Organic Chemistry|June 23, 2018
Directed Cu(I)-Catalyzed Carbomagnesiation of 1-Arylcycloprop-2-ene-1-carboxamides En Route to Densely Substituted Functionalized CyclopropanesAndrew Edwards, Michael Rubin
Clinical Advances in Hematology & Oncology : H&O|April 29, 2009
Amphiphysin autoimmunity in paraneoplastic neurologic diseaseLakshmi Nayak, Michael Rubin
Organic & Biomolecular Chemistry|February 12, 2016
Efficient one-pot synthesis of 1-arylcycloprop-2-ene-1-carboxamidesAndrew Edwards, Michael Rubin
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 1, 2006
Efficacy of topical cyclosporin 0.05% in the treatment of posterior blepharitisMichael Rubin, Sanjay N Rao
The Neurologist|January 10, 2009
Paraneoplastic neurological syndromes: a reviewThomas B Toothaker, Michael Rubin
Journal of the American Chemical Society|September 23, 2008
Rhodium-catalyzed hydroformylation of cyclopropenesWilliam M Sherrill, Michael Rubin
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Continuum (Minneapolis, Minn.)|August 5, 2017
Shared Medical Decision Making in Consideration of Opioid Therapy in a Patient With Restless Legs SyndromeMichael Rubin
The American Journal of Bioethics : AJOB|June 14, 2016
Should We Offer Blood Transfusions as a Palliative Therapy?Michael Rubin
The Journal of Supportive Oncology|August 12, 2005
Paraneoplastic syndromes and the nervous systemMichael Rubin
The New England Journal of Medicine|October 11, 2013
Observation careJodi Nudelman, Michael Rubin
The Journal of Organic Chemistry|June 23, 2018
Directed Cu(I)-Catalyzed Carbomagnesiation of 1-Arylcycloprop-2-ene-1-carboxamides En Route to Densely Substituted Functionalized CyclopropanesAndrew Edwards, Michael Rubin
Clinical Advances in Hematology & Oncology : H&O|April 29, 2009
Amphiphysin autoimmunity in paraneoplastic neurologic diseaseLakshmi Nayak, Michael Rubin
Organic & Biomolecular Chemistry|February 12, 2016
Efficient one-pot synthesis of 1-arylcycloprop-2-ene-1-carboxamidesAndrew Edwards, Michael Rubin
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 1, 2006
Efficacy of topical cyclosporin 0.05% in the treatment of posterior blepharitisMichael Rubin, Sanjay N Rao
The Neurologist|January 10, 2009
Paraneoplastic neurological syndromes: a reviewThomas B Toothaker, Michael Rubin
Journal of the American Chemical Society|September 23, 2008
Rhodium-catalyzed hydroformylation of cyclopropenesWilliam M Sherrill, Michael Rubin
Pageof 14